ClinicalTrials.gg
Sign In

Blastic Plasmacytoid Dendritic Cell Neoplasm clinical trials

The registry lists 45 studies for Blastic Plasmacytoid Dendritic Cell Neoplasm across more than 10 countries. 15 are recruiting or about to start. 17 of them are mainly about Blastic Plasmacytoid Dendritic Cell Neoplasm (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-26.

Get an email when these change. Save the Blastic Plasmacytoid Dendritic Cell Neoplasm studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Recruiting
14
Completed
13
Active, not recruiting
8
Terminated
7
Withdrawn
2
Not yet recruiting
1

Phase

Phase 1
23
Phase 2
20
Early Phase 1
1

Where

United States
33
Italy
6
France
4
Germany
4
United Kingdom
3
China
3

Who runs them

Fred Hutchinson Cancer Center (8) · M.D. Anderson Cancer Center (4) · City of Hope Medical Center (3) · Stemline Therapeutics, Inc. (3) · Mayo Clinic (3) · Mustang Bio (2) · Centre Hospitalier Universitaire de Besancon (2) · Dana-Farber Cancer Institute (2)

What is being tested here

Drugs under test in Blastic Plasmacytoid Dendritic Cell Neoplasm studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Tagraxofusp406
Fludarabine304
Cyclophosphamide304
Venetoclax204
Fludarabine phosphate102
Allogeneic CD34+-enriched and CD45RA-depleted PBSCs101
Azacitidine101
Mesna101
Rituximab101
Adrixetinib101

Drug classes tested here Antimetabolites 4 open

Coming up

0phase 3 studies under way
8studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 8

Who these studies take

Of the 14 Blastic Plasmacytoid Dendritic Cell Neoplasm studies recruiting now, 7 (50%) set no upper age limit and 6 (43%) stop at 75 or younger. 6 (43%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 14
AgeWomenMen
106 (43%)6 (43%)
1814 (100%)14 (100%)
3012 (86%)12 (86%)
4012 (86%)12 (86%)
5012 (86%)12 (86%)
6512 (86%)12 (86%)
7511 (79%)11 (79%)
857 (50%)7 (50%)

Across all 45 studies, recruiting or not: 31% stop at 75 or younger and 13% at 65; 40% take children; 0% are for women only and 0% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 14, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 45 of 45. search them.